Even een korte weergave van de waarde van Tigenix op dit moment
Totale beurswaarde nu 107-108 miljoen
cash medio maart 2015 35 miljoen
Dat houdt dus in dat de hele pijplijn van Tigenix op dit moment gewaardeerd word op ca 72 miljoen !? Met fase 3/ CX601 (klaar) 2 procucten fase 1 + 1 procuct fase 2
+ een gelicenseerd product al verkopend
Volgens mij het goedkoopst gewaardeerde bedrijf met zo'n vergevorderde pijplijn .
De manipulatie ( analisten / beleggers) en liegen van sommige luitjes gaat onverminderd door .
Zouden bijna vergeten dat er komende dagen belangrijke biotechconferences zijn .
17-20 March: International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium
Participant: Marie-Paule Richard, Chief Medical Officer
Request meeting
19 March: KBC Securities Institutional Healthcare Conference, Brussels, Belgium
Participants: Eduardo Bravo, Chief Executive Officer; Claudia D’Augusta, Chief Financial Officer
Request meeting
21 March: FlandersBio KBC Lifescience Retail Investor Event, Leuven, Belgium
Presenter: Wilfried Dalemans, Chief Technical Officer
Request meeting
25 March: ARM Annual Regenerative Medicine Investor Day, New York, USA
Presenter: Eduardo Bravo, Chief Executive Officer
Request meeting
26 March: Bio Capital Amsterdam, Amsterdam, Netherlands
Participant: Claudia D’Augusta, Chief Financial Officer
Request meeting
16 April: Kempen Healthcare and Life Sciences Conference, New York, USA
Participant: Claudia D’Augusta, Chief Financial Officer
Request meeting
25 April: FedInvest VFB Happening, Brussels, Belgium
Presenter: Eduardo Bravo, Chief Executive Officer
Request meeting
27-28 April: CF&B European Small Cap Event, Paris, France
Participant: Claudia D’Augusta, Chief Financial Officer
Request meeting
16-19 May: Digestive Disease Week, Washington, USA
Participant: Marie-Paule Richard, Chief Medical Officer
Request meeting
20-22 May: Annual World Stem Cell and Regenerative Medecine Congress, London, UK
Participants: Eduardo Bravo, Chief Executive Officer; Claudia Jimenez, Senior Director Business Development
Request meeting
21 May: Knowledge for Growth, Ghent, Belgium
Presenter: Wilfried Dalemans, Chief Technical Officer
Request meeting
2-3 June: PDA Europe Advanced Therapy Medicinal Products Conference, Amsterdam, Netherlands
Moderator: Wilfried Dalemans, Chief Technical Officer Participant: Maria Pascual, Vice President Regulatory Affairs and Corporate Quality
Request meeting
10-13 June: EULAR Annual European Congress of Rheumatology, Rome, Italy
Participant: Marie-Paule Richard, Chief Medical Officer
Request meeting
15-18 June: Bio International Convention 2015, Philadelphia, USA
Participants: Eduardo Bravo, Chief Executive Officer; Claudia Jimenez, Senior Director Business Development
Request meeting
24-27 June: International Society for Stem Cell Research Annual Meeting, Stockholm, Sweden
Participant: Wilfried Dalemans, Chief Technical Officer
Request meeting